GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 216 filers reported holding GENMAB A/S in Q2 2024. The put-call ratio across all filers is 4.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3 | -40.0% | 102 | -40.7% | 0.00% | – |
| Q1 2024 | $5 | 0.0% | 172 | 0.0% | 0.00% | – |
| Q4 2023 | $5 | -16.7% | 172 | 0.0% | 0.00% | – |
| Q3 2023 | $6 | -14.3% | 172 | 0.0% | 0.00% | – |
| Q2 2023 | $7 | +16.7% | 172 | 0.0% | 0.00% | – |
| Q1 2023 | $6 | -14.3% | 172 | 0.0% | 0.00% | – |
| Q4 2022 | $7 | -99.8% | 172 | +25.5% | 0.00% | – |
| Q3 2022 | $4,000 | 0.0% | 137 | 0.0% | 0.00% | – |
| Q2 2022 | $4,000 | -20.0% | 137 | 0.0% | 0.00% | – |
| Q1 2022 | $5,000 | 0.0% | 137 | 0.0% | 0.00% | – |
| Q4 2021 | $5,000 | -28.6% | 137 | -17.0% | 0.00% | – |
| Q3 2021 | $7,000 | +75.0% | 165 | +91.9% | 0.00% | – |
| Q2 2021 | $4,000 | +33.3% | 86 | 0.0% | 0.00% | – |
| Q1 2021 | $3,000 | 0.0% | 86 | 0.0% | 0.00% | – |
| Q4 2020 | $3,000 | -57.1% | 86 | -55.9% | 0.00% | – |
| Q3 2020 | $7,000 | +75.0% | 195 | +14.0% | 0.00% | – |
| Q2 2020 | $4,000 | 0.0% | 171 | 0.0% | 0.00% | – |
| Q1 2020 | $4,000 | 0.0% | 171 | 0.0% | 0.00% | – |
| Q4 2019 | $4,000 | – | 171 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 214,848 | $6,980,000 | 2.38% |
| Cutter & CO Brokerage, Inc. | 119,956 | $3,897,000 | 1.33% |
| Hardman Johnston Global Advisors LLC | 933,449 | $30,328,000 | 1.29% |
| Connective Portfolio Management, LLC | 18,000 | $585,000 | 1.00% |
| Capricorn Fund Managers Ltd | 148,411 | $4,822,000 | 0.88% |
| TORRAY INVESTMENT PARTNERS LLC | 131,708 | $4,279,000 | 0.82% |
| First Light Asset Management, LLC | 160,885 | $5,227,000 | 0.61% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 1,857 | $57,189,000 | 0.60% |
| Yorktown Management & Research Co Inc | 10,100 | $328,000 | 0.42% |
| Integrated Investment Consultants, LLC | 18,550 | $602,000 | 0.22% |